CSL Behring is a global biotherapeutics leader driven by its promise to save lives. We develop and deliver innovative therapies for people with rare and serious diseases, including those with bleeding disorders, immune deficiencies, and other life-threatening conditions. Our expertise lies in plasma-derived and recombinant therapies. As a member of the CSL Group (ASX:CSL), CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The company is committed to research and development to address unmet medical needs and improve patients' lives worldwide.
The King of Prussia headquarters serves as the central hub for CSL Behring's global operations, including executive leadership, strategic planning, research and development oversight, and corporate functions.
The campus features modern office buildings and advanced laboratory spaces designed to foster collaboration and innovation. It includes facilities for research, product development, and global operational management.
The work culture at CSL Behring's headquarters is characterized by a strong focus on patient well-being, scientific excellence, integrity, and collaboration. Employees are driven by the company's mission to save and improve lives.
This location is significant due to its proximity to other major life science organizations, academic institutions, and a skilled talent pool, facilitating partnerships and innovation in the biopharmaceutical sector.
CSL Behring supports a wide range of functions globally, including research and development in multiple specialized centers, state-of-the-art manufacturing facilities across several continents, an extensive plasma collection network (CSL Plasma), and commercial operations in over 100 countries. This ensures the development, production, and delivery of its life-saving therapies to patients worldwide.
1020 First Avenue
King of Prussia
Pennsylvania
USA
Address: Emil-von-Behring-Strasse 76, 35041 Marburg, Germany
Serves as a key operational center for Europe, focusing on manufacturing excellence, research, and development for plasma-derived therapies.
Address: Wankdorfstrasse 10, 3014 Bern, Switzerland
Focuses on innovation in immunology and coagulation, supporting the development and supply of products for the European and global markets.
Address: 189-209 Camp Road, Broadmeadows VIC 3047, Australia
Key hub for the Asia-Pacific region, involved in the end-to-end process from research to manufacturing and distribution of biotherapies and vaccines.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, CSL Behring' leadership includes:
CSL Behring has been backed by several prominent investors over the years, including:
CSL Limited, the parent company of CSL Behring, experienced a significant leadership transition with the appointment of a new CEO.
Discover the tools CSL Behring uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
CSL Behring commonly uses the firstname.lastname@cslbehring.com email format for its employees. Variations may exist for specific departments or regions, but this is the most prevalent structure.
firstname.lastname@cslbehring.com
Format
john.doe@cslbehring.com
Example
90%
Success rate
CSL News • May 7, 2024
CSL Behring announced that the U.S. Food and Drug Administration (FDA) has approved a new dosing option for Hizentra® (Immune Globulin Subcutaneous [Human], 20% Liquid) that allows for self-administration using an infusion pump. This provides greater flexibility for patients with primary immunodeficiency (PI) and chronic inflammatory demyelinating polyneuropathy (CIDP)....more
CSL News • April 30, 2024
CSL announced positive topline results from the VANGUARD Phase 3 clinical trial evaluating the efficacy and safety of garadacimab (CSL312) as a prophylactic treatment for patients with hereditary angioedema (HAE). The study met its primary efficacy endpoint....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including CSL Behring, are just a search away.